GlaxoSmithKline cuts 350 research jobs
| June 12, 2008 |  View for printing |
GlaxoSmithKline (GSK), the world's second-largest drugmaker, said Wednesday it is cutting 350 jobs, or around 2% of its research staff, as part of an ongoing restructuring plan aimed at boosting productivity.
Like other drugmakers, Glaxo is encountering declining earnings. The drugmaker faces increasing competition with generics, setbacks to products and fewer potential future drugs in production.
By Jane Wardell, AP Business Writer
Full Story: http://www.usatoday.com/money/compan ... -cuts_N.htm
No reader comments so far. Be the first to comment by clicking the button below.
Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.
